Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-12-017955)

Filing Details

Accession Number:: 0001209191-12-017955
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-03-13 18:36:16
Reporting Period:: 2012-03-09

Filing Date:: 2012-03-13
Accepted Time:: 2012-03-13 18:36:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
353569	Quidel Corp	QDEL	In Vitro & In Vivo Diagnostic Substances (2835)	942573850

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1298084	D Thomas Brown	29890 Tanya Trail Libertyville IL 60048		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-03-09	5,482	$5.59	19,310	No	4	M	Direct
Common Stock	Disposition	2012-03-09	5,482	$16.13	13,828	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock	Disposition	2012-03-09	5,482	$0.00	5,482	$5.59

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2005-12-13	2014-12-13	No	4	M	Direct

Footnotes

The weighted average sale price for these transactions was $16.1301 per share, with a range of $15.92 to $16.205 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.